Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Orchid Pharma has informed that it enclosed the disclosure on Related Party Transactions, on a consolidated basis, prepared in accordance with the applicable accounting standards for the half year ended March 31, 2022. This disclosure will also be made available on the website of the Company and can be accessed using the link http://www.orchidpharma.com/invr_intimation.aspx.
The above information is a part of company’s filings submitted to BSE.
